Loading...
XIDX
INAF
Market cap21mUSD
Jul 01, Last price  
126.00IDR
Name

Indofarma Tbk PT

Chart & Performance

D1W1MN
XIDX:INAF chart
P/E
—
P/S
2.58
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-38.45%
Revenues
151.55b
-27.96%
1,026,675,533,9391,273,162,479,1641,478,585,255,3951,125,055,390,9361,047,918,156,4701,203,466,970,6521,156,050,256,7201,337,498,191,7101,381,436,578,1151,621,898,667,6571,674,702,722,3281,631,317,499,0961,592,979,941,2581,359,175,249,6551,715,587,654,3992,901,986,532,8791,144,108,230,742523,599,087,434210,379,674,000151,550,542,000
Net income
-77.99b
L-76.68%
15,240,675,13811,076,807,0485,031,898,6802,125,637,96712,546,644,38836,919,316,55142,384,956,906-54,222,344,1421,166,073,4876,566,935,986-17,366,640,817-46,282,940,175-32,735,901,4287,960,962,72427,580,910-37,571,241,226-428,487,671,595-720,993,176,197-334,488,575,000-77,989,297,000
CFO
-209.89b
L+869.30%
73,151,865,24383,418,335,788-187,307,305,04840,557,994,67723,713,155,86929,396,516,728-40,914,557,262-141,616,973,090148,726,901,608134,284,985,660-317,962,543,661147,184,447,849-70,390,895,93120,790,922,34746,547,903,55392,899,478,946-75,946,136,115-190,104,481,175-21,653,684,335-209,890,099,000
Dividend
May 03, 20131.37 IDR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
URL
https://indofarma.id/en/
IPO date
Apr 17, 2001
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT